Literature DB >> 16902395

HIV counseling, testing, and care of tuberculosis patients at chest clinics--Guyana, 2005-2006.

.   

Abstract

Tuberculosis (TB) is a leading cause of morbidity and mortality among persons living with human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS). During 2004, Guyana had an estimated TB incidence rate of 140 per 100,000 population, the fourth highest rate in the Americas (after Haiti, Bolivia, and Peru); Guyana also had an estimated adult HIV prevalence of 2.5%, and 20% of TB patients were reported to be infected with HIV. In 2000, the Guyana Ministry of Health (MOH) began providing HIV counseling, testing, and referrals to HIV/AIDS programs at its six public chest clinics. At the end of 2005, chest clinics also began providing co-trimoxazole preventive therapy (CPT) to HIV-infected TB patients as a measure against common opportunistic infections. During February-June 2006, an international team assessed the extent to which MOH chest clinics in Guyana had implemented these interventions during July 2005-June 2006. This report summarizes the results of that assessment, which determined that, among 253 TB patients sampled, 174 (69%) initially did not know their HIV-infection status; 127 (73%) of those patients were offered HIV counseling and testing, and 115 (91%) accepted and were tested for HIV. Of the 115 who were tested, 11 (10%) were determined to be HIV infected; overall, 68 (35%) of the 194 patients whose HIV-infection status was known were HIV infected (i.e., 11 who were tested at the chest clinics plus 57 with preexisting knowledge of their HIV status). These results indicate both a high rate of HIV infection among TB patients in Guyana and the ability of chest clinics to provide HIV-related interventions in resource-limited settings.

Entities:  

Mesh:

Year:  2006        PMID: 16902395

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  4 in total

1.  A cluster-randomized trial of provider-initiated (opt-out) HIV counseling and testing of tuberculosis patients in South Africa.

Authors:  Diana S Pope; Andrea N Deluca; Paula Kali; Harry Hausler; Carol Sheard; Ebrahim Hoosain; Mohammad A Chaudhary; David D Celentano; Richard E Chaisson
Journal:  J Acquir Immune Defic Syndr       Date:  2008-06-01       Impact factor: 3.731

2.  Missed opportunities for diagnosis of tuberculosis and human immunodeficiency virus co-infection in Moshi, Tanzania.

Authors:  A C Tribble; C D Hamilton; J A Crump; A Mgonja; A Mtalo; E Ndanu; D K Itemba; K Z Landman; M Shorter; E M Ndosi; J F Shao; J A Bartlett; N M Thielman
Journal:  Int J Tuberc Lung Dis       Date:  2009-10       Impact factor: 2.373

3.  Scale-up of collaborative TB/HIV activities in Guyana.

Authors:  Brian J Baker; Brandy Peterson; Jeetendra Mohanlall; Shanti Singh; Collene Hicks; Ruth Jacobs; Ruth Ramos; Barbara Allen; Eric Pevzner
Journal:  Rev Panam Salud Publica       Date:  2017-04-20

4.  Adherence to tuberculosis therapy among patients receiving home-based directly observed treatment: evidence from the United Republic of Tanzania.

Authors:  Abdallah Mkopi; Nyagosya Range; Fred Lwilla; Saidi Egwaga; Alexander Schulze; Eveline Geubbels; Frank van Leth
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.